Citation Impact
Citing Papers
Subpolar addition of new cell wall is directed by DivIVA in mycobacteria
2014 StandoutNobel
Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
1998
Imaging Mycobacterial Trehalose Glycolipids
2017 StandoutNobel
HLA-Class II-Associated Control of Antigen Recognition by T Cells in Leprosy: A Prominent Role for the 30/31-kDa Antigens
1999
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis
2010
Intravital Imaging Reveals Limited Antigen Presentation and T Cell Effector Function in Mycobacterial Granulomas
2011
Therapy of tuberculosis in mice by DNA vaccination
1999 Nature
The success and failure of BCG — implications for a novel tuberculosis vaccine
2005
Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis
2006
How can immunology contribute to the control of tuberculosis?
2001
DNA vaccines: a key for inducing long-term cellular immunity
2000
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
Th1/Th2 Cells
1999
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope
1999
The immunology of susceptibility and resistance to Leishmania major in mice
2002 Standout
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model
2004
Design and development of polymers for gene delivery
2005 Standout
Mucosal immunity and vaccines
2005 Standout
Elucidation and Chemical Modulation of Sulfolipid-1 Biosynthesis in Mycobacterium tuberculosis
2011 StandoutNobel
Mycobacterium tuberculosis Antigen 85A and 85C Structures Confirm Binding Orientation and Conserved Substrate Specificity
2004
Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations
2007
Identification, function and structure of the mycobacterial sulfotransferase that initiates sulfolipid-1 biosynthesis
2004 StandoutNobel
Bacteria as DNA vaccine carriers for genetic immunization
2004
Delivery technologies for cancer immunotherapy
2019 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
Trehalose Is Required for Growth of Mycobacterium smegmatis
2004 StandoutNobel
Are the PE‐PGRS proteins of Mycobacterium tuberculosis variable surface antigens?
2002
Mycobacterium tuberculosis Antigen 85A Induces Th-1 Immune Responses in Systemic Sarcoidosis
2007
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
2007 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
DNA encoding a single mycobacterial antigen protects against leprosy infection
2001
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
2007 Standout
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Leprosy
2004 Standout
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Specificity of CD8+ T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis
1997
Kinetic measurements and mechanism determination of Stf0 sulfotransferase using mass spectrometry
2005 StandoutNobel
Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivo
2002
Fighting tuberculosis: An old disease with new challenges
2004
Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis
1997
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
2003
Defining trained immunity and its role in health and disease
2020 Standout
Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus
2006 StandoutNobel
Sarcoidosis
2007 Standout
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity
1997
Immunization with f-Met peptides induces immune reactivity against Mycobacterium tuberculosis
2000
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Leishmaniasis
1999 Standout
The Immune Response in Human Tuberculosis—Implications for Tuberculosis Control
1997
Genetic Immunization of Mice Against Listeria monocytogenes Using Plasmid DNA Encoding Listeriolysin O
1999
Induction of a Th1 Immune Response and Simultaneous Lack of Activation of a Th2 Response Are Required for Generation of Immunity to Leishmaniasis
1998
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
Genetic Immunization Generates Cellular and Humoral Immune Responses Against the Nonstructural Proteins of the Hepatitis C Virus in a Murine Model
1998
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Immunology of Tuberculosis
2001 Standout
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
2002 Standout
Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis
2004
Catalytic Asymmetric Synthesis of Phthioceranic Acid, a Heptamethyl-Branched Acid from Mycobacterium tuberculosis
2007 StandoutNobel
Interaction of dendritic cells with mycobacteria: Where the action starts
2000
Cutinase‐like proteins of Mycobacterium tuberculosis : characterization of their variable enzymatic functions and active site identification
2009
Effective Preexposure Tuberculosis Vaccines Fail To Protect When They Are Given in an Immunotherapeutic Mode
2000
Cutting Edge: IFN-γ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection
2006
Gene Therapy for Infectious Diseases
1998
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer
2000
Toll-Like Receptor 2-Dependent Inhibition of Macrophage Class II MHC Expression and Antigen Processing by 19-kDa Lipoprotein ofMycobacterium tuberculosis
2001
Cytokine Profiles for Peripheral Blood Lymphocytes from Patients with Active Pulmonary Tuberculosis and Healthy Household Contacts in Response to the 30-Kilodalton Antigen ofMycobacterium tuberculosis
1998
Quantitative Proteomic Profiling of Host−Pathogen Interactions: The Macrophage Response to Mycobacterium tuberculosis Lipids
2008 StandoutNobel
Characterization of Human CD8+ T Cells Reactive with Mycobacterium tuberculosis–infected Antigen-presenting Cells
1998
Genetic Heterogeneity ofBorrelia burgdorferiSensu Lato inIxodes ricinusTicks Collected in Belgium
1998
CTL Response toMycobacterium tuberculosis: Identification of an Immunogenic Epitope in the 19-kDa Lipoprotein
1998
Application of Mycobacterial Proteomics to Vaccine Design: Improved Protection by Mycobacterium bovis BCG Prime-Rv3407 DNA Boost Vaccination against Tuberculosis
2004
ListeriaPathogenesis and Molecular Virulence Determinants
2001 Standout
Human cytolytic and interferon γ-secreting CD8+T lymphocytes specific forMycobacterium tuberculosis
1998
Mycobacterium tuberculosis-Reactive CD8+ T Lymphocytes: The Relative Contribution of Classical Versus Nonclassical HLA Restriction
2000
The complete genomic sequence of Nocardia farcinica IFM 10152
2004 Standout
Pulmonary Necrosis Resulting from DNA Vaccination against Tuberculosis
2003
A sulfated metabolite produced bystf3negatively regulates the virulence ofMycobacteriumtuberculosis
2006 StandoutNobel
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Enhanced Immunogenicity of CD4+T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis
2001
Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis
2007
Disruption of the Genes Encoding Antigen 85A and Antigen 85B of Mycobacterium tuberculosis H37Rv: Effect on Growth in Culture and in Macrophages
2000
Central Memory and Effector Memory T Cell Subsets: Function, Generation, and Maintenance
2004 Standout
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
2004
Direct Visualization of the Outer Membrane of Mycobacteria and Corynebacteria in Their Native State
2008 StandoutNobel
The Immune Response in Tuberculosis
2013 Standout
The tuberculosis epidemic. Scientific challenges and opportunities.
1998
DNA vaccines: an historical perspective and view to the future
2010
Th1/Th2 cells
2007
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B
2005
Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization
2007
Genetic requirements for mycobacterial survival during infection
2003 Standout
Factors Associated with Severe Granulomatous Pneumonia inMycobacterium tuberculosis-Infected Mice Vaccinated Therapeutically with hsp65 DNA
2005
Vaccination with DNA Encoding the Immunodominant LACK Parasite Antigen Confers Protective Immunity to Mice Infected with Leishmania major
1997
Influence of ESAT-6 Secretion System 1 (RD1) of Mycobacterium tuberculosis on the Interaction between Mycobacteria and the Host Immune System
2005
Phenotypical and Functional Analysis of Memory and Effector Human CD8 T Cells Specific for Mycobacterial Antigens
2006
Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis
2018
T Cell Reactivity against Mycolyl Transferase Antigen 85 ofM. tuberculosisin HIV-TB Coinfected Subjects and in AIDS Patients Suffering from Tuberculosis and Nontuberculous Mycobacterial Infections
2010
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
DNA VACCINES
1997
The Continuing Challenges of Leprosy
2006 Standout
Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guerin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara
2003
Works of E Lozes being referenced
La maladie de Lyme en Belgique: présence du spirochète Borrelia burgdorferi dans les tiques Ixodes ricinus récoltées dans la région mosane.
1989
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex
1997
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
1996
Cross‐Reactive Immune Responses Against Mycobacterium bovis BCG in Mice Infected with Non‐Tuberculous Mycobacteria Belonging to the MAIS‐Group
1997
Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice
1997
Immunogenicity and Protective Efficacy of Tuberculosis DNA Vaccines Encoding Putative Phosphate Transport Receptors
1999
[Lyme disease in Belgium: presence of the spirochete Borrelia burgdorferi in Ixodes ricinus ticks recovered from the Meuse River region].
1989
Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG
1994